About Solventum
Solventum is a company based in Saint Paul (United States) founded in 2023. The company has 22,000 employees as of December 31, 2024. Solventum has completed 1 acquisition, including Acera Surgical. Solventum operates in a competitive market with competitors including UMC Utrecht, Pasteur Institute, AngelEye Health, Fakeeh Care Group and Weill Cornell Medicine, among others.
- Headquarter Saint Paul, United States
- Employees 22000 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Solventum Corporation
-
Annual Revenue
$8.25 B (USD)0.7as on Dec 31, 2024
-
Net Profit
$479 M (USD)-64.41as on Dec 31, 2024
-
EBITDA
$1.63 B (USD)-27.74as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
22000
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Solventum
Solventum is a publicly listed company on the NYSE with ticker symbol SOLV in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Solventum
Detailed funding history for Solventum
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Solventum
Solventum has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Acera Surgical.
Investment portfolio details for Solventum
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Synthetic electrospun scaffolds are provided for regenerative medical uses.
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for Solventum
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Solventum
Detailed financials for Solventum
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Solventum Comparisons
Peer comparison for Solventum
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Solventum
Solventum operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as UMC Utrecht, Pasteur Institute, AngelEye Health, Fakeeh Care Group and Weill Cornell Medicine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Healthcare education and training services are provided to professionals.
|
|
| Locked | Locked | Locked |
Provider of healthcare education services
|
|
| Locked | Locked | Locked |
Provider of NICU cameras, communication, feed management, and education services for hospitals
|
|
| Locked | Locked | Locked |
A leading healthcare provider in Saudi Arabia, expanding into Dubai's healthcare and medical education markets.
|
|
| Locked | Locked | Locked |
Provider of medical education, research, and patient care. This organization offers MD and graduate degree programs, conducts cutting-edge biomedical research, and delivers exemplary patient care through affiliated hospitals. Faculty are engaged in clinical practice and scientific discovery, translating breakthroughs into improved treatments and prevention strategies. The institution fosters a culture of mentorship and supports global health initiatives. Educational programs are highly selective and include international partnerships. Research focuses on advancing knowledge in areas such as cancer and cardiovascular disease.
|
|
| Locked | Locked | Locked |
Diagnostic, digital health, and education services are provided.
|
Detailed competitors of Solventum
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Solventum
Complete news archive for Solventum
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Solventum
Solventum was founded in 2023.
Solventum is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
Bryan Hanson is the current CEO of Solventum.
As of Dec 31, 2024, the latest employee count at Solventum is 22,000.
Annual revenue of Solventum is $8.25B as on Dec 31, 2024.
Solventum was founded in 2023 and is headquartered in Saint Paul, United States. Operations are centered in the healthcare sector, where medical products are developed and manufactured alongside medical education services. Focus is placed on innovation in these areas to support healthcare needs. The company serves markets through its domain, solventum.com, with Bryan Hanson serving as CEO.
Solventum's top competitors include Weill Cornell Medicine, UMC Utrecht and College of American Pathologists.
Yes, Solventum is publicly traded on NYSE under the ticker symbol SOLV.
Solventum has made 1 acquisition, including Acera Surgical.
The ticker symbol of Solventum is SOLV on NYSE.